|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
This article has been cited by other articles:
![]() |
J. Harris, S. Oliere, S. Sharma, Q. Sun, R. Lin, J. Hiscott, and N. Grandvaux Nuclear Accumulation of cRel following C-Terminal phosphorylation by TBK1/IKK{epsilon} J. Immunol., August 15, 2006; 177(4): 2527 - 2535. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Ritchie, A. O. W. Yam, K. M. Tanabe, S. A. Rice, and M. A. Cooley Modification of In Vivo and In Vitro T- and B-Cell-Mediated Immune Responses by the Pseudomonas aeruginosa Quorum-Sensing Molecule N-(3-Oxododecanoyl)-L-Homoserine Lactone Infect. Immun., August 1, 2003; 71(8): 4421 - 4431. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Bhakar, L.-L. Tannis, C. Zeindler, M. P. Russo, C. Jobin, D. S. Park, S. MacPherson, and P. A. Barker Constitutive Nuclear Factor-kappa B Activity Is Required for Central Neuron Survival J. Neurosci., October 1, 2002; 22(19): 8466 - 8475. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Speirs, J. Caamano, M. H. Goldschmidt, C. A. Hunter, and P. Scott NF-{kappa}B2 Is Required for Optimal CD40-Induced IL-12 Production but Dispensable for Th1 Cell Differentiation J. Immunol., May 1, 2002; 168(9): 4406 - 4413. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Pohl, R. Gugasyan, R. J. Grumont, A. Strasser, D. Metcalf, D. Tarlinton, W. Sha, D. Baltimore, and S. Gerondakis The combined absence of NF-kappa B1 and c-Rel reveals that overlapping roles for these transcription factors in the B cell lineage are restricted to the activation and function of mature cells PNAS, April 2, 2002; 99(7): 4514 - 4519. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chen, L. C. Edelstein, and C. Gélinas The Rel/NF-kappa B Family Directly Activates Expression of the Apoptosis Inhibitor Bcl-xL Mol. Cell. Biol., April 15, 2000; 20(8): 2687 - 2695. [Abstract] [Full Text] |
||||
![]() |
M. Grossmann, D. Metcalf, J. Merryfull, A. Beg, D. Baltimore, and S. Gerondakis The combined absence of the transcription factors Rel and RelA leads to multiple hemopoietic cell defects PNAS, October 12, 1999; 96(21): 11848 - 11853. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Harling-McNabb, G. Deliyannis, D. C. Jackson, S. Gerondakis, G. Grigoriadis, and L. E. Brown Mice lacking the transcription factor subunit Rel can clear an influenza infection and have functional anti-viral cytotoxic T cells but do not develop an optimal antibody response Int. Immunol., September 1, 1999; 11(9): 1431 - 1439. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-X. Zong, L. C. Edelstein, C. Chen, J. Bash, and C. Gélinas The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappa B that blocks TNFalpha -induced apoptosis Genes & Dev., February 15, 1999; 13(4): 382 - 387. [Abstract] [Full Text] |
||||
![]() |
D. Carrasco, J. Cheng, A. Lewin, G. Warr, H. Yang, C. Rizzo, F. Rosas, C. Snapper, and R. Bravo Multiple Hemopoietic Defects and Lymphoid Hyperplasia in Mice Lacking the Transcriptional Activation Domain of the c-Rel Protein J. Exp. Med., April 6, 1998; 187(7): 973 - 984. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ishikawa, E. Claudio, D. Dambach, C. Raventos-Suarez, C. Ryan, and R. Bravo Chronic Inflammation and Susceptibility to Bacterial Infections in Mice Lacking the Polypeptide (p)105 Precursor (NF-{kappa}B1) but Expressing p50 J. Exp. Med., April 6, 1998; 187(7): 985 - 996. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kistler, A. Rolink, R. Marienfeld, M. Neumann, and T. Wirth Induction of Nuclear Factor-{kappa}B During Primary B Cell Differentiation J. Immunol., March 1, 1998; 160(5): 2308 - 2317. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Sha Regulation of Immune Responses by NF-{kappa}B/Rel Transcription Factors J. Exp. Med., January 19, 1998; 187(2): 143 - 146. [Full Text] [PDF] |
||||
![]() |
G. Franzoso, L. Carlson, L. Xing, L. Poljak, E. W. Shores, K. D. Brown, A. Leonardi, T. Tran, B. F. Boyce, and U. Siebenlist Requirement for NF-kappa B in osteoclast and B-cell development Genes & Dev., December 15, 1997; 11(24): 3482 - 3496. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ishikawa, D. Carrasco, E. Claudio, R.-P. Ryseck, and R. Bravo Gastric Hyperplasia and Increased Proliferative Responses of Lymphocytes in Mice Lacking the COOH-terminal Ankyrin Domain of NF-{kappa}B2 J. Exp. Med., October 6, 1997; 186(7): 999 - 1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Carrasco, P. Perez, A. Lewin, and R. Bravo I{kappa}B{alpha} Overexpression Delays Tumor Formation in v-rel Transgenic Mice J. Exp. Med., July 21, 1997; 186(2): 279 - 288. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Doi, T. Takahashi, O. Taguchi, T. Azuma, and Y. Obata NF-{kappa}B RelA-deficient Lymphocytes: Normal Development of T Cells and B Cells, Impaired Production of IgA and IgG1 and Reduced Proliferative Responses J. Exp. Med., March 3, 1997; 185(5): 953 - 962. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schmidt-Ullrich, S. Memet, A. Lilienbaum, J. Feuillard, M. Raphael, and A. Israel NF-kappaB activity in transgenic mice: developmental regulation and tissue specificity Development, July 1, 1996; 122(7): 2117 - 2128. [Abstract] [PDF] |
||||
![]() |
T. Kurihara and R. Bravo Cloning and Functional Expression of mCCR2, a Murine Receptor for the C-C Chemokines JE and FIC J. Biol. Chem., May 17, 1996; 271(20): 11603 - 11606. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||